Dinesh Mahajan

3rd Milestone, Faridabad Gurugram Expressway
Faridabad, HR 121001, India

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 22 publications

Recombinant live biotherapeutics against chronic metabolic diseases: Challenges and opportunities.

Recombinant live biotherapeutics against chronic metabolic diseases: Challenges and opportunities.

Journal: Progress in molecular biology and translational science

Published: February 19, 2026

Carbamate Prodrugs Restrict In Vivo Metabolism and Improve the Pharmacokinetics of Isoniazid.

Carbamate Prodrugs Restrict In Vivo Metabolism and Improve the Pharmacokinetics of Isoniazid.

Journal: ACS central science

Published: April 01, 2025

Erratum: Collinsella aerofaciens linked with increased ethanol production and liver inflammation contribute to the pathophysiology of NAFLD.

Erratum: Collinsella aerofaciens linked with increased ethanol production and liver inflammation contribute to the pathophysiology of NAFLD.

Journal: iScience

Published: March 04, 2025

Itaconate mechanism of action and dissimilation in Mycobacterium tuberculosis.

Itaconate mechanism of action and dissimilation in Mycobacterium tuberculosis.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: January 22, 2025

Isoniazid-historical development, metabolism associated toxicity and a perspective on its pharmacological improvement.

Isoniazid-historical development, metabolism associated toxicity and a perspective on its pharmacological improvement.

Journal: Frontiers in pharmacology

Published: May 30, 2024

NAFLD-associated hepatocellular carcinoma (HCC) - A compelling case for repositioning of existing mTORc1 inhibitors.

NAFLD-associated hepatocellular carcinoma (HCC) - A compelling case for repositioning of existing mTORc1 inhibitors.

Journal: Pharmacological research

Published: May 10, 2024

Identification and optimization of pyridine carboxamide-based scaffold as a drug lead for Mycobacterium tuberculosis.

Identification and optimization of pyridine carboxamide-based scaffold as a drug lead for Mycobacterium tuberculosis.

Journal: Antimicrobial agents and chemotherapy

Published: January 09, 2024

Collinsella aerofaciens linked with increased ethanol production and liver inflammation contribute to the pathophysiology of NAFLD.

Collinsella aerofaciens linked with increased ethanol production and liver inflammation contribute to the pathophysiology of NAFLD.

Journal: iScience

Published: July 18, 2023

Methotrimeprazine is a neuroprotective antiviral in JEV infection via adaptive ER stress and autophagy.

Methotrimeprazine is a neuroprotective antiviral in JEV infection via adaptive ER stress and autophagy.

Journal: EMBO molecular medicine

Published: April 05, 2023

Editorial: Antibiotic potentiators against drug-resistant pathogens: Discovery, development and clinical applications.

Editorial: Antibiotic potentiators against drug-resistant pathogens: Discovery, development and clinical applications.

Journal: Frontiers in microbiology

Published: February 25, 2023

Human Gut Microbiota and Drug Metabolism.

Human Gut Microbiota and Drug Metabolism.

Journal: Microbial ecology

Published: January 29, 2022

Saroglitazar and Hepano treatment offers protection against high fat high fructose diet induced obesity, insulin resistance and steatosis by modulating various class of hepatic and circulating lipids.

Saroglitazar and Hepano treatment offers protection against high fat high fructose diet induced obesity, insulin resistance and steatosis by modulating various class of hepatic and circulating lipids.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: August 16, 2021

Showing 1-12 of 22

Last Updated: 09/26/2026